Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells

According to common beliefs, conventional anticancer chemotherapy is deleterious for the immune system. We have recently provided in vitro evidence indicating that conventional chemotherapy may potentiate, rather than impair, the long-term efficacy of γδ T cell-based anticancer immunotherapy.

Detalles Bibliográficos
Autores principales: Todaro, Matilde, Meraviglia, Serena, Caccamo, Nadia, Stassi, Giorgio, Dieli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825724/
https://www.ncbi.nlm.nih.gov/pubmed/24244907
http://dx.doi.org/10.4161/onci.25821
_version_ 1782290838386114560
author Todaro, Matilde
Meraviglia, Serena
Caccamo, Nadia
Stassi, Giorgio
Dieli, Francesco
author_facet Todaro, Matilde
Meraviglia, Serena
Caccamo, Nadia
Stassi, Giorgio
Dieli, Francesco
author_sort Todaro, Matilde
collection PubMed
description According to common beliefs, conventional anticancer chemotherapy is deleterious for the immune system. We have recently provided in vitro evidence indicating that conventional chemotherapy may potentiate, rather than impair, the long-term efficacy of γδ T cell-based anticancer immunotherapy.
format Online
Article
Text
id pubmed-3825724
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-38257242013-11-15 Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells Todaro, Matilde Meraviglia, Serena Caccamo, Nadia Stassi, Giorgio Dieli, Francesco Oncoimmunology Author's View According to common beliefs, conventional anticancer chemotherapy is deleterious for the immune system. We have recently provided in vitro evidence indicating that conventional chemotherapy may potentiate, rather than impair, the long-term efficacy of γδ T cell-based anticancer immunotherapy. Landes Bioscience 2013-09-01 2013-07-29 /pmc/articles/PMC3825724/ /pubmed/24244907 http://dx.doi.org/10.4161/onci.25821 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Todaro, Matilde
Meraviglia, Serena
Caccamo, Nadia
Stassi, Giorgio
Dieli, Francesco
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
title Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
title_full Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
title_fullStr Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
title_full_unstemmed Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
title_short Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
title_sort combining conventional chemotherapy and γδ t cell-based immunotherapy to target cancer-initiating cells
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825724/
https://www.ncbi.nlm.nih.gov/pubmed/24244907
http://dx.doi.org/10.4161/onci.25821
work_keys_str_mv AT todaromatilde combiningconventionalchemotherapyandgdtcellbasedimmunotherapytotargetcancerinitiatingcells
AT meravigliaserena combiningconventionalchemotherapyandgdtcellbasedimmunotherapytotargetcancerinitiatingcells
AT caccamonadia combiningconventionalchemotherapyandgdtcellbasedimmunotherapytotargetcancerinitiatingcells
AT stassigiorgio combiningconventionalchemotherapyandgdtcellbasedimmunotherapytotargetcancerinitiatingcells
AT dielifrancesco combiningconventionalchemotherapyandgdtcellbasedimmunotherapytotargetcancerinitiatingcells

Ejemplares similares